Article info
Paper
Biological activity of interferon betas in patients with multiple sclerosis is affected by treatment regimen and neutralising antibodies
- Correspondence to: Dr A Bertolotto Centro Riferimento Regionale Sclerosi Multipla (CReSM) and Neurobiologia Clinica, ASO S. Luigi Gonzaga, Regione Gonzole 10, 10043, Orbassano, Torino, Italy; sclerosi.multiplasanluigi.piemonte.it
Citation
Biological activity of interferon betas in patients with multiple sclerosis is affected by treatment regimen and neutralising antibodies
Publication history
- Received January 20, 2004
- Accepted May 14, 2004
- Revised April 21, 2004
- First published August 16, 2004.
Online issue publication
April 13, 2016
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2004 Journal of Neurology Neurosurgery and Psychiatry